Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Shire Plc Ads (SHPG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,706,176
  • Shares Outstanding, K 305,280
  • Annual Sales, $ 15,161 M
  • Annual Income, $ 4,272 M
  • 60-Month Beta 0.87
  • Price/Sales 3.48
  • Price/Cash Flow N/A
  • Price/Book 1.46
  • Price/Earnings ttm 11.21
  • Earnings Per Share ttm 15.36
  • Most Recent Earnings 3.64 on 11/01/18
  • Next Earnings Date 02/13/19
  • Annual Dividend & Yield 0.34 (0.00%)
  • Most Recent Dividend 0.168 on 09/06/18
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 3.78
  • Number of Estimates 6
  • High Estimate 3.87
  • Low Estimate 3.67
  • Prior Year 3.98
  • Growth Rate Est. (year over year) -5.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
165.29 +8.42%
on 12/18/18
181.22 -1.11%
on 01/04/19
+7.70 (+4.49%)
since 12/04/18
3-Month
165.29 +8.42%
on 12/18/18
182.47 -1.79%
on 11/12/18
+2.35 (+1.33%)
since 10/04/18
52-Week
123.73 +44.83%
on 02/09/18
182.47 -1.79%
on 11/12/18
+21.91 (+13.93%)
since 01/04/18

Most Recent Stories

More News
Ophthalmic Drugs Market 2018 Global Industry Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023

An expert on premium research reports, Market Research Future has added a report titled to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market...

VRX.TO : 30.80 (-3.33%)
SNPHF : 14.8000 (-2.31%)
MRK : 81.72 (+0.45%)
AGN : 154.10 (+2.16%)
SHPG : 179.20 (+4.10%)
TEVA : 16.93 (+1.74%)
REGN : 407.94 (+0.08%)
PFE : 42.26 (+1.08%)
Ophthalmic Drugs Market to Expand at a steady Growth Rate in the Coming Years

The global ophthalmic drugs market is expected to register significant growth in the forecoming years. Major factors driving growth of the global ophthalmic drugs markets are, increasing prevalence and...

VRX.TO : 30.80 (-3.33%)
SNPHF : 14.8000 (-2.31%)
AGN : 154.10 (+2.16%)
NVS : 93.25 (+0.09%)
SHPG : 179.20 (+4.10%)
TEVA : 16.93 (+1.74%)
REGN : 407.94 (+0.08%)
Scheme becomes effective

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION...

SHPG : 179.20 (+4.10%)
Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today that the Company has completed the acquisition of a manufacturing facility...

SHPG : 179.20 (+4.10%)
Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today that the Company has completed the acquisition of a manufacturing facility...

SHPG : 179.20 (+4.10%)
Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the Acquisition of Shire plc

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") notes Shire plc's ("Shire") announcement that the Royal Court of Jersey (the "Jersey Court") has today sanctioned the...

SHPG : 179.20 (+4.10%)
TKPYY : 16.5900 (-0.90%)
Japan : Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange

Takeda Pharmaceutical Company Limited (TSE: 4502) (Takeda) today announced that the listing and trading of its American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE) is expected to commence...

THE.TO : 17.75 (+1.37%)
BK : 53.87 (-0.20%)
SHPG : 179.20 (+4.10%)
Annual Changes to the NASDAQ-100 Index

Nasdaq (Nasdaq: NDAQ) today announced the results of the annual re-ranking of the NASDAQ-100 Index(R) (Nasdaq: NDX), which will become effective prior to market open on Monday, December 24, 2018.

UAL : 81.68 (+1.18%)
NDAQ : 84.82 (+0.69%)
SHPG : 179.20 (+4.10%)
VOD : 19.28 (+1.00%)
WLTW : 173.60 (-0.28%)
QQQ : 179.70 (+0.70%)
LULU : 146.02 (+1.17%)
NTAP : 67.27 (+0.54%)
HOLX : 47.42 (+0.51%)
ESRX : 92.33 (-3.62%)
QRTEA : 17.44 (+0.87%)
STX : 47.75 (-0.85%)
AMD : 24.84 (+6.84%)
VRSN : 182.72 (+1.00%)
Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger

Shire's (SHPG) pending acquisition by Takeda Pharmaceuticals for $62 billion gets approval from shareholders of both the companies.

AGN : 154.10 (+2.16%)
BMRN : 92.37 (-1.06%)
INCY : 85.61 (-0.01%)
SHPG : 179.20 (+4.10%)
Is the Options Market Predicting a Spike in Shire (SHPG) Stock?

Investors need to pay close attention to Shire (SHPG) stock based on the movements in the options market lately.

SHPG : 179.20 (+4.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade SHPG with:

Business Summary

Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)

See More

Key Turning Points

2nd Resistance Point 184.22
1st Resistance Point 181.71
Last Price 179.20
1st Support Level 176.20
2nd Support Level 173.20

See More

52-Week High 182.47
Last Price 179.20
Fibonacci 61.8% 160.03
Fibonacci 50% 153.10
Fibonacci 38.2% 146.17
52-Week Low 123.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar